iPSCs offer several advantages over other types of stem cells. One of the most significant benefits is their ability to be derived from the patient's own cells, eliminating the ethical concerns associated with the use of embryonic stem cells (ESCs) and reducing the risk of immune rejection. Additionally, iPSCs can be generated from a wide variety of cell types, making them highly versatile for different research and clinical applications. Their pluripotent nature allows them to differentiate into any cell type, providing a robust tool for studying development and disease.
